Although Nrf2 activation is an important antioxidant modulator in normal cells, this effect is also one of the main factors involved in the enhanced resistance to chemotherapy and radiotherapy in cancer cells since many studies are focused to reduce Nrf2 activation in chemoresistant and radioresistant cancer cells [34,35,36]. Here, NFE2L2 is linked to cancer.